Oruka Therapeutics Files Proxy Statement for June Meeting
Ticker: ORKA · Form: DEF 14A · Filed: Apr 18, 2025 · CIK: 907654
| Field | Detail |
|---|---|
| Company | Oruka Therapeutics, Inc. (ORKA) |
| Form Type | DEF 14A |
| Filed Date | Apr 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Oruka Therapeutics (ORKA) proxy filed for June 2nd meeting. Shareholders vote soon.
AI Summary
Oruka Therapeutics, Inc. filed its definitive proxy statement on April 18, 2025, for its annual meeting on June 2, 2025. The company, formerly known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC, is headquartered in Menlo Park, CA. This filing is a standard procedural document for shareholder voting on corporate matters.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions on company governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or strategic changes that would inherently increase risk.
Key Numbers
- 20250602 — Annual Meeting Date (Date of the shareholder meeting for which the proxy is filed.)
- 20250418 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- Oruka Therapeutics, Inc. (company) — Registrant
- ARCA biopharma, Inc. (company) — Former company name
- NUVELO INC (company) — Former company name
- HYSEQ INC (company) — Former company name
- Menlo Park, CA (location) — Business address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing details on matters to be voted upon.
When is the Oruka Therapeutics, Inc. annual meeting scheduled?
The annual meeting for Oruka Therapeutics, Inc. is scheduled for June 2, 2025.
What was Oruka Therapeutics, Inc. previously known as?
Oruka Therapeutics, Inc. was formerly known as ARCA biopharma, Inc., NUVELO INC, and HYSEQ INC.
Where is Oruka Therapeutics, Inc. located?
Oruka Therapeutics, Inc. is located at 855 Oak Grove Ave., Suite 100, Menlo Park, CA 94025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 18, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 18, 2025 regarding Oruka Therapeutics, Inc. (ORKA).